A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Lichen Sclerosus

NCT05593445 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Lichen Sclerosus

Interventions

DRUG: Ruxolitinib cream
DRUG: Vehicle cream

Sponsor

Incyte Corporation